Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 217


DAF in diabetic patients is subject to glycation/inactivation at its active site residues.

Flückiger R, Cocuzzi E, Nagaraj RH, Shoham M, Kern TS, Medof ME.

Mol Immunol. 2018 Jan;93:246-252. doi: 10.1016/j.molimm.2017.06.036. Epub 2017 Sep 5.


Lack of Association of CD55 Receptor Genetic Variants and Severe Malaria in Ghanaian Children.

Schuldt K, Ehmen C, Sievertsen J, Evans J, May J, Ansong D, Muntau B, Ruge G, Timmann C, Agbenyega T, Horstmann RD, Thye T.

G3 (Bethesda). 2017 Mar 10;7(3):859-864. doi: 10.1534/g3.116.036475.


A common CD55 rs2564978 variant is associated with the susceptibility of non-small cell lung cancer.

Zhang Y, Zhang Z, Cao L, Lin J, Yang Z, Zhang X.

Oncotarget. 2017 Jan 24;8(4):6216-6221. doi: 10.18632/oncotarget.14053.


Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.

Kwon YC, Kim H, Meyer K, Di Bisceglie AM, Ray R.

J Immunol. 2016 Aug 15;197(4):1127-36. doi: 10.4049/jimmunol.1600631. Epub 2016 Jun 29.


Modulation of PBMC-decay accelerating factor (PBMC-DAF) and cytokines in rheumatoid arthritis.

Pahwa R, Kumar U, Das N.

Mol Cell Biochem. 2016 Mar;414(1-2):85-94. doi: 10.1007/s11010-016-2661-x. Epub 2016 Feb 23.


Overexpression of CD55 from Barrett's esophagus is associated with esophageal adenocarcinoma risk.

Murao T, Shiotani A, Fujita Y, Yamanaka Y, Kamada T, Manabe N, Hata J, Nishio K, Haruma K.

J Gastroenterol Hepatol. 2016 Jan;31(1):99-106. doi: 10.1111/jgh.13055.


Malaria. A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion.

Egan ES, Jiang RH, Moechtar MA, Barteneva NS, Weekes MP, Nobre LV, Gygi SP, Paulo JA, Frantzreb C, Tani Y, Takahashi J, Watanabe S, Goldberg J, Paul AS, Brugnara C, Root DE, Wiegand RC, Doench JG, Duraisingh MT.

Science. 2015 May 8;348(6235):711-4. doi: 10.1126/science.aaa3526.


Complement inhibitor CD55 governs the integrity of membrane rafts in pancreatic beta cells, but plays no role in insulin secretion.

Nagaraj V, King B, Storm P, Vikman P, Ottosson-Laakso E, Blom AM, Renström E.

Biochem Biophys Res Commun. 2015 May 8;460(3):518-24. doi: 10.1016/j.bbrc.2015.03.062. Epub 2015 Mar 19.


The tag SNP rs10746463 in decay-accelerating factor is associated with the susceptibility to gastric cancer.

Song Q, Zhang Z, Liu Y, Han S, Zhang X.

Mol Immunol. 2015 Feb;63(2):473-8.


Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment.

Pan J, Zhang L, Organtini LJ, Hafenstein S, Bergelson JM.

J Virol. 2015 Jan 15;89(2):1324-8. doi: 10.1128/JVI.02798-14. Epub 2014 Nov 12.


Expression of CD55 on red blood cells of β-thalassemia patients.

Obaid JM, Abo El-Nazar SY, Ghanem AM, El-Hadidi AS, Mersal BH.

Hemoglobin. 2014;38(5):339-44. doi: 10.3109/03630269.2014.935787. Epub 2014 Jul 15.


CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of α-gal xenoantigen in colon tumor cells.

Wu Y, Wang Y, Qin F, Wang Z, Wang Y, Yang Y, Zheng H, Wang Y.

Am J Physiol Gastrointest Liver Physiol. 2014 Jun 15;306(12):G1056-64. doi: 10.1152/ajpgi.00464.2013. Epub 2014 Apr 24.


CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype.

Sutavani RV, Bradley RG, Ramage JM, Jackson AM, Durrant LG, Spendlove I.

J Immunol. 2013 Dec 15;191(12):5895-903. doi: 10.4049/jimmunol.1301458. Epub 2013 Nov 6.


Characterization of novel CD55 isoforms expression in normal and neoplastic tissues.

Vainer ED, Meir K, Furman M, Semenenko I, Konikoff F, Vainer GW.

Tissue Antigens. 2013 Jul;82(1):26-34. doi: 10.1111/tan.12138. Epub 2013 May 21.


Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles.

Mazumdar B, Kim H, Meyer K, Bose SK, Di Bisceglie AM, Ray RB, Diamond MS, Atkinson JP, Ray R.

J Virol. 2013 Jul;87(14):7902-10. doi: 10.1128/JVI.00917-13. Epub 2013 May 8.


DAF as a therapeutic target for steroid hormones: implications for host-pathogen interactions.

Nowicki B, Nowicki S.

Adv Exp Med Biol. 2013;735:83-96. Review.


CD55 polymorphisms and risk of aspirin‑exacerbated respiratory disease.

Lee JS, Bae JS, Kim JH, Kim JY, Park TJ, Pasaje CF, Park BL, Cheong HS, Uh ST, Jang AS, Choi IS, Park CS, Shin HD.

Mol Med Rep. 2012 Nov;6(5):1087-92. doi: 10.3892/mmr.2012.1064. Epub 2012 Sep 5.


A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection.

Zhou J, To KK, Dong H, Cheng ZS, Lau CC, Poon VK, Fan YH, Song YQ, Tse H, Chan KH, Zheng BJ, Zhao GP, Yuen KY.

J Infect Dis. 2012 Aug 15;206(4):495-503. doi: 10.1093/infdis/jis378. Epub 2012 Jun 12.


Nitric oxide induces segregation of decay accelerating factor (DAF or CD55) from the membrane lipid-rafts and its internalization in human endometrial cells.

Banadakoppa M, Goluszko P, Liebenthal D, Yallampalli C.

Cell Biol Int. 2012 Oct 1;36(10):901-7. doi: 10.1042/CBI20110586.


A single amino acid substitution controls DAF-dependent phenotype of echovirus 11 in rhabdomyosarcoma cells.

Novoselov AV, Rezaykin AV, Sergeev AG, Fadeyev FA, Grigoryeva JV, Sokolova ZI.

Virus Res. 2012 Jun;166(1-2):87-96. doi: 10.1016/j.virusres.2012.03.007. Epub 2012 Mar 15.


Supplemental Content

Support Center